Literature DB >> 27902997

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.

Jacques Reynolds1, George Sachs1, Kara Stavros1.   

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired immune-mediated disorder characterized by weakness and sensory deficits that can lead to significant neurological disability. The diagnosis is based on a combination of clinical examination findings, electrodiagnostic studies, and other supportive evidence. Recognizing CIDP and distinguishing it from other chronic polyneuropathies is important because many patients with CIDP are highly responsive to treatment with immunosuppressive or immunomodulatory therapies. This review summarizes the clinical features, diagnosis, and current treatment strategies for CIDP. [Full article available at http://rimed.org/rimedicaljournal-2016-12.asp].

Entities:  

Keywords:  CIDP; chronic inflammatory demyelinating polyradiculoneuropathy; immune-mediated neuropathy; polyneuropathy

Mesh:

Year:  2016        PMID: 27902997

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  4 in total

1.  Chronic inflammatory demyelinating polyneuropathy: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials.

Authors:  Giuseppe Magliulo; Giannicola Iannella; Alessandra Manno; Laura Libonati; Emanuela Onesti; Annarita Vestri; Danilo Alunni Fegatelli; Diletta Angeletti; Annalisa Pace; Giampiero Gulotta; Silvia Gagliardi; Maurizio Inghilleri
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-27       Impact factor: 2.503

2.  Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.

Authors:  Angelo Maurizio Clerici; Eduardo Nobile-Orazio; Marco Mauri; Federico Sergio Squellati; Giorgio Giovanni Bono
Journal:  BMC Neurol       Date:  2017-07-01       Impact factor: 2.474

3.  Anesthetic management of a patient with chronic inflammatory demyelinating polyneuropathy by combination of total intravenous and regional anesthesia.

Authors:  Daiki Takekawa; Kishiko Nakai; Hirotaka Kinoshita; Junichi Saito; Masato Kitayama; Tetsuya Kushikata; Kazuyoshi Hirota
Journal:  JA Clin Rep       Date:  2019-03-09

4.  Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple Sclerosis.

Authors:  Michael Auer; Harald Hegen; Anna Hotter; Wolfgang Löscher; Klaus Berek; Anne Zinganell; Elena Fava; Paul Rhomberg; Florian Deisenhammer; Franziska Di Pauli
Journal:  J Cent Nerv Syst Dis       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.